Abstract:Africa CDC recently conducted a comprehensive risk ranking assessment of epidemic-prone diseases across the continent, identifying Ebola as one of the top 19 infectious diseases with the highest scores in disease severity risk and epidemic potential. The Ebolaviruses first described in the Democratic Republic of the Congo (DRC) in 1976 have left a harrowing trail across sub-Saharan Africa, triggering no less than 34 Ebola outbreaks in 11 sub-Saharan Africa countries, a statistic further compounded by the recent outbreak in Uganda in 2022. At present, the World Health Organization (WHO) has approved two Ebola vaccines, including Ervebo and two-component Zabdeno and Mvabea boost vaccines, for use by individuals above the age of 1 year, including pregnant women as per the Strategic Advisory Group of Experts on Immunization (SAGE) recommendations. The use of these vaccines has demonstrated noteworthy efficacy in safeguarding against Ebola in most African communities and frontline health workers in Ebola-endemic countries such as Sierra Leone, Guinea, and Liberia, among others. Unfortunately, the uptake of these vaccines in Ebola-endemic countries remains dishearteningly constrained despite their availability due to, among other things, the unpredictable timing of outbreaks, sub-optimal surveillance, vaccine demand volatility, palpable vaccine hesitancy, and fragile health infrastructure. Addressing these challenges requires a multifaceted approach that includes a synergy of partnerships between governments, communities, development partners, and private sector partners, such as pharmaceuticals. Recognizing that outbreaks originate and seize at the community level, the imperative of confronting hesitancy through sustained proactive community engagement and utilizing promising vaccination strategies such as ring vaccination must be encouraged. Governments must increase investments to strengthen the regulatory environment for timely access to vaccine stockpiles, robust and cost-effective Ebola vaccination programs for at-risk populations, and preventative use for the health workforce. The International Coordinating Group (ICG) on Vaccine Provision also recommends that national and international health authorities initiate vaccine access by submitting a request to the ICG. This opportunity is at no cost for GAVI-eligible countries and on a reimbursement basis for non-eligible countries. In parallel, Africa CDC is also working closely with Member States on the continent to increase availability and access to medical countermeasures, which include therapeutics, vaccines, and diagnostics, making it critical that Africa CDC is included in the ICG. This will promote timely issue profiling and resolution for increased demand for vaccine stockpiles across the continent where they are needed most as the continent moves towards enhanced health security.

Ebola virus disease in West Africa-The first 9 months: To the editor [2]

Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections

Exposure patterns driving Ebola transmission in West Africa: A retrospective observational study

A Historical Review of Ebola Outbreaks

Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries

Critiquing the response to the Ebola epidemic through a Primary Health Care Approach

The Ebola outbreak, 2013–2016: old lessons for new epidemics

Are Surveillance Response Systems Enough to Effectively Combat and Contain the Ebola Outbreak?

The Potential Impact of Increased Hospital Capacity to Contain and Control Ebola in Liberia

Forty years of the war against Ebola

How to prepare for the next inevitable Ebola outbreak: lessons from West Africa

Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

Recent advances in the treatment of Ebola disease: A brief overview

Ebola Cases and Health System Demand in Liberia

Acquired immunity and asymptomatic reservoir impact on frontline and airport ebola outbreak syndromic surveillance and response

Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness

The Ebola Threat: China’s Response to the West African Epidemic and National Development of Prevention and Control Policies and Infrastructure

[Response to Ebola Virus Disease Outbreak: Experience in Field Epidemiology in Sierra Leone]

Shielding Africa, Protecting the World: Unleashing the Power of Preventative Use of Ebola Vaccines